Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine Effects on Gastrointestinal Transit
NCT00332137Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolterodine in Urinary urge incontinence (UUI), sponsored by Mayo Clinic. Started Sep 2005; status: completed.
02
Drugs
tolterodine
03
Conditions
Urinary urge incontinence (UUI)
Beyond the preview
Go deeper on NCT00332137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332137.